1. Home >
  2. Companies >
  3. Public >
  4. Medical Products >
  5. United Kingdom >
  6. Hikma >
  7. M&A

Hikma Mergers & Acquisitions

Hikma M&A Summary

Hikma has acquired 10 companies, including 2 in the last 5 years. A total of 2 acquisitions came from private equity firms.

Hikma’s largest acquisition to date was in 2021, when it acquired Custopharm for $375M. Hikma has acquired in 4 different US states, and 5 countries. The Company’s most targeted sectors include medical products (50%) and life science (40%).

M&A Summary

  • M&A Total Activity10
    • M&A Buy Activity10
  • Total Sectors Invested 3
  • Total Countries Invested 5
  • M&A Buy/Sell Connections 3

Hikma

Hikma Pharmaceuticals PLC

1 New Burlington Place,
London, W1S 1HW
United Kingdom,
+44 20 7399 2760
www.hikma.com

All (10) Buy (10) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2022-01-17 Teligent - Sterile Injectable Assets · Life Science
Mississauga, Ontario

Teligent's Sterile Injectable Assets includes a portfolio of 25 sterile injectable products, three in-licensed ophthalmic products, and a pipeline of seven additional products. Teligent's Sterile Injectable Assets are based in Mississauga, Ontario.

46 Divestiture

Hikma

Teligent


Try Mergr Free — See This and 221,329+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal